================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report September 20, 2004
SURGICARE, INC.
(Exact Name of Registrant as Specified in Its Charter)
DELAWARE 001-16587 58-1597246
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
10700 Richmond Ave., Suite 300
HOUSTON, TEXAS 77042
(Address of principal executive offices)
(713) 973-6675
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
================================================================================
ITEM 3.02. UNREGISTERED SALES OF EQUITY SECURITIES
On September 20, 2004, SurgiCare, Inc. (the "Company") issued 8,750,000 shares
of common stock in connection to an agreement with American International
Industries, Inc. ("AII") dated June 23, 2004 (press release filed on July 1,
2004) to convert the Company's 900,000 shares of Series AA Redeemable Preferred
Stock held by AII. All other terms of the agreement were consummated August 2,
2004. The shares were issued upon approval of the listing of the shares on the
American Stock Exchange obtained September 20, 2004. The stock was issued in
reliance on the exemption provided by Section 4(2) of the Securities Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SURGICARE, INC.
Date: September 22, 2004 By: /s/ Keith LeBlanc
---------------------------------
Keith LeBlanc
President and Chief Executive Officer
-2-